Anavex Life Sciences Corp (AVXL)

[stealthways]

drug $ cuts force BP to scramble for new tech:
The gov has a lot of control over generics, and ensuring more competition in the same ... this is fairly obvious. For RX drugs, the gov can still lower them as well by showing what they sell for in other countries .... this will cause drug cos to raise RX prices internationally and lower them in the states... Stateside generics will drop significantly overall, and RX will drop but less than Generics, stateside..
So how will leading pharma companies counteract this ... by embracing innovation (read chasing), and hopefully being a leader, in the development of new proprietary drugs (where they have more pricing power and no competition) that can benefit society ... This will be a huge tailwind for avxl and other bio cos that have promising new tech to benefit the healthcare system...times are changing...